U.S. Capital Markets Stock News

Northwest Natural Holding recently marked its 70th consecutive annual dividend increase, maintaining a dividend yield of about 4.0% while continuing to invest heavily in its regulated utility operations. This long dividend track record, combined with expansion into fast-growing Texas markets via the SiEnergy acquisition and a multi-billion-dollar capital plan, underscores how management is prioritizing both income and long-term infrastructure growth. Next, we’ll examine how this 70-year...

Intapp (INTA) has drawn fresh attention after announcing a partnership with Legora to deliver governed AI workflows for law firms, alongside new Celeste powered compliance and timekeeping products aimed at professional services firms. These AI product launches appear to have coincided with a sharp shift in momentum for Intapp, with a 30 day share price return of 37.26% and a 90 day share price return of 88.26%. This contrasts with a year to date share price move that is slightly down and a 1...

Regency Centers has delivered a 36.6% return over the past three years, and current valuation work suggests the stock may still trade below an estimate of its intrinsic value. The Discounted Cash Flow (DCF) view and market multiples both point to a potential valuation gap, even after that multi year gain. The 36.6% three year return suggests investors have already been rewarded, so any remaining upside depends on how much cash flow the business can produce and retain over time. For Regency...

IREN stock presents a sharp contrast between its very large three year gain and valuation checks that currently flag it as expensive rather than a clear bargain. For investors trying to make sense of the recent swings, the question is how that strong past return lines up with today’s pricing on more traditional value screens. IREN is up roughly 7x over the past three years, which puts extra focus on whether recent pricing already reflects much of the good news in the story. The push into AI...

Teva Pharmaceutical Industries (NYSE:TEVA) agreed to acquire a neuroscience asset from BioXcel Therapeutics involving a sublingual film for agitation in schizophrenia and bipolar disorder patients through a court supervised bankruptcy sale. The product is under FDA review, and the transaction remains subject to court approval as of late August 2026. The deal aligns with Teva's stated Pivot to Growth strategy and adds to its focus on neuroscience treatments. For readers looking to explore...

Element Solutions (NYSE:ESI) and Solstice Advanced Materials agreed to mutually terminate their previously announced merger agreement, with no termination fees payable by either side. The decision follows shareholder feedback and board discussions that reassessed the planned combination and its proposed leadership structure. Element Solutions plans to focus on operating as a standalone company and recommitting to its independent strategy following the cancelled merger. Element Solutions is...

Cisco Systems recently expanded its Secure AI Factory with NVIDIA by adding Super Micro Computer’s liquid- and air‑cooled high‑density GPU systems, and also launched a Sovereign Critical Infrastructure portfolio in Canada, enabling air‑gapped, on‑premises deployments across networking, security, collaboration, and observability. Together, these moves deepen Cisco’s role in high‑performance AI infrastructure while addressing rising demand from governments and critical industries for...

Ally Financial (ALLY) has drawn investor attention after recent trading saw the stock close at US$42.18. The move comes as shareholders weigh its value score, recent returns and core automotive finance exposure. Over the past year, Ally Financial has seen short term share price returns drift lower, with the 30 day share price return down 1.79% and the year to date share price return down 7.82%. However, the 1 year total shareholder return of 5.72% and 3 year total shareholder return of 60.58%...

In the past quarter, ArcBest Corporation reported strong second-quarter 2026 results, with adjusted earnings topping expectations and both Asset-Based and Asset-Light segments delivering meaningful year-over-year revenue growth, supported by pricing initiatives, cost optimization, higher managed volumes, and favorable capacity conditions. An interesting aspect of this report is how the Asset-Light segment’s very large revenue increase underscores the growing importance of managed solutions...

Republic Services (RSG) is in focus after partnering with the City of Coconut Creek to deploy six fully electric, zero emission recycling and waste collection trucks, highlighting the company’s approach to sustainability in its core operations. For context, Republic Services’ share price has gained 10.81% over the past 90 days and 5.67% year to date, while its one year total shareholder return is down 3.98%. Its three and five year total shareholder returns of 58.67% and 88.52% point to...

RH stock performance overview after recent trading move RH (RH) drew investor attention after the latest trading session, with the stock closing at $149.49. Recent returns show a 3.2% gain over the past day but a decline over the past month. Over the past 3 months, RH has been roughly flat, while returns over the past year, 3 years, and 5 years show declines. Year to date, the stock is also down, leaving the company with a market value of about $2.7b. For investors tracking fundamentals, RH...

The OpenAI and Cursor breakup has turned vendor risk in AI from a background concern into front page news and it puts fresh attention on software stocks that help developers stay flexible about which AI models they use. That shift could matter for where AI spend flows next and for which companies build stronger pricing power. This article looks at 3 stocks exposed to this news and why each might interest, or worry, you as an investor. The stocks covered below are just a sample of this theme...

Pfizer (NYSE:PFE) has reached a settlement resolving thousands of federal lawsuits alleging its contraceptive Depo-Provera caused intracranial meningiomas. The agreement covers claims over alleged brain tumor risks tied to long term use of Depo-Provera, with settlement terms reported as confidential. The resolution marks a significant legal and reputational moment for Pfizer and may influence investor risk perception and future drug safety litigation across the sector. For more ideas in...

Tutor Perini has delivered an extremely strong share price run over the past three years, yet current checks based on an intrinsic value estimate and market multiples both still point to the stock trading below these valuation markers. That combination of a very large historical gain with ongoing signs of undervaluation is what investors now need to weigh most carefully. Over the past three years, Tutor Perini has returned a very large multiple on the share price, which makes any fresh...

ICF International (ICFI) recently announced a $20 million recompete contract to continue leading energy efficiency and electrification programs for a consortium of Northeast utilities, putting the company’s implementation capabilities in focus for investors. Set against this contract win, ICF International’s share price has shown firm upward momentum in recent months, with a 30 day share price return of 8.66% and a 90 day share price return of 31.06%, even though the 1 year total shareholder...

Cheesecake Factory stock has delivered very strong returns in recent years, and the latest valuation checks suggest the shares now lean expensive rather than clearly cheap. Cheesecake Factory has returned about 277.1% over the past 3 years, which puts recent gains front and centre in any valuation discussion. Expectations around the company’s ability to sustain restaurant traffic and protect margins can support the current share price, while any pressure on costs or consumer demand may...

Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap. Over 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing. The...

In the past quarter, Allstate reported strong second-quarter results marked by higher premiums, improved net income and a better combined ratio, helped by a mild catastrophe season. A key shift was in homeowners insurance, which moved from an underwriting loss to income as fewer catastrophe losses and rate increases improved segment profitability, even as consumers continued to face higher premiums and constrained coverage options. Next, we’ll examine how this improved catastrophe experience...

Attention is turning back to USA Rare Earth (USAR) as the company prepares to present at the 15th Annual Needham Virtual Industrial Tech, Robotics, & Power 1x1 Conference on August 17, 2026. The recent pullback, including a 1 day share price decline of 6.55% to $17.99 and a 7 day share price decline of 6.59%, comes after a sharp 30 day share price gain of 37.64%. The 3 year total shareholder return of 76.98% suggests longer term momentum has still been positive. Scan beyond USA Rare Earth and...

Federated Hermes stock has delivered strong multiyear gains, yet current valuation checks suggest the recent share price around US$64 is roughly in line with an internally estimated intrinsic value rather than clearly cheap or expensive. The Excess Returns model points to a fair value close to the market price, while earnings based multiples also signal pricing that looks about right. Over the past 5 years the stock has returned about 138%, which leaves investors asking whether much of the...

Copart stock has had a tough year, with a sharply weaker share price set against valuation checks that point to a possible discount versus its estimated intrinsic value. The Discounted Cash Flow (DCF) estimate suggests the intrinsic value is higher than where Copart currently trades, while market-based multiples look closer to fair. Over the past 1 year, Copart has declined 32.4%, which means recent returns have been challenging despite a longer term business story that has not materially...

UnitedHealth Group (UNH) drew fresh investor attention after reporting Q2 2026 results that beat revenue and earnings expectations, with management raising full-year adjusted EPS guidance and highlighting tighter cost control across key healthcare segments. UnitedHealth Group's latest Q2 beat and higher full-year EPS guidance arrive after a mixed share price pattern, with the stock up 16.8% year to date but only a 1.5% total shareholder return over five years. This suggests long-term momentum...

Red Cat Holdings (RCAT) has moved into focus after announcing a partnership between its Blue Ops maritime division and Havoc. The agreement centers on integrating Havoc autonomy and command systems across Blue Ops uncrewed surface vessels. The Havoc partnership lands after a sharp pullback in Red Cat Holdings’ share price, with the stock down 8.51% over the last day and 11.75% over the past week. A 25.41% 30 day share price return suggests shorter term momentum has picked up. Over a longer...

In late August 2026, SPX Technologies drew renewed attention as analysts highlighted broad agreement that the company could outperform earlier earnings expectations, supported by its rising operating margins, long-term EPS growth, and expanding free cash flow margin. What stands out is how this consensus on stronger earnings is underpinned by tangible profitability gains, suggesting that sentiment is being driven less by hype and more by the company’s improving financial efficiency. Next,...